DSM signs biologics development and manufacturing agreement with Australian firm

DSM Pharmaceutical Products (Parsippany, NJ), the business unit of DSM which provides contract manufacturing and development services to the pharma and biopharma industries, says it has signed a biologics contract manufacturing agreement with Paranta Biosciences (Melbourne). Financial terms were not disclosed. Paranta Biosciences is an early stage drug development company that develops and commercializes biotherapeutics based on recombinant human follistatin for the treatment of respiratory diseases. The contract covers the process development and manufacture by...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers